FLDM - Fluidigm Corporation

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
4.68
-0.01 (-0.21%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close4.69
Open4.70
Bid3.03 x 2400
Ask5.98 x 1500
Day's Range4.65 - 4.87
52 Week Range2.52 - 8.69
Volume175,920
Avg. Volume368,067
Market Cap137.66M
Beta4.39
PE Ratio (TTM)-1.91
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETFs with exposure to Fluidigm Corp. : October 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Fluidigm Corp. Here are 5 ETFs with the largest exposure to FLDM-US. Comparing the performance and risk of Fluidigm Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Should You Be Concerned About Fluidigm Corporation’s (FLDM) Risks?
    Simply Wall St.19 days ago

    Should You Be Concerned About Fluidigm Corporation’s (FLDM) Risks?

    If you are a shareholder in Fluidigm Corporation’s (NASDAQ:FLDM), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of your portfolioRead More...

  • Capital Cube2 months ago

    ETFs with exposure to Fluidigm Corp. : August 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Fluidigm Corp. Here are 5 ETFs with the largest exposure to FLDM-US. Comparing the performance and risk of Fluidigm Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Fluidigm (FLDM) Licenses CFTR Assay From Baylor Genetics
    Zacks2 months ago

    Fluidigm (FLDM) Licenses CFTR Assay From Baylor Genetics

    Fluidigm (FLDM) has licensed rights to commercialize the cystic fibrosis transmembrane conductance regulator. The company is focused on improving its Juno automated microfluidic system.

  • Fluidigm Corp. :FLDM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
    Capital Cube2 months ago

    Fluidigm Corp. :FLDM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Fluidigm Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Fluidigm Corp. – Illumina, Inc., NanoString Technologies, Inc., Thermo Fisher Scientific Inc., Luminex Corp, PerkinElmer, Inc., Pacific Biosciences of California, Inc. and Bio-Rad Laboratories, Inc. Class A (ILMN-US, NSTG-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of FLDM earnings conference call or presentation 3-Aug-17 9:00pm GMT

    Q2 2017 Fluidigm Corp Earnings Call

  • Associated Press2 months ago

    Fluidigm reports 2Q loss

    On a per-share basis, the South San Francisco, California-based company said it had a loss of 58 cents. Losses, adjusted for one-time gains and costs, came to 31 cents per share. The company that makes ...

  • Capital Cube3 months ago

    ETFs with exposure to Fluidigm Corp. : July 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Fluidigm Corp. Here are 5 ETFs with the largest exposure to FLDM-US. Comparing the performance and risk of Fluidigm Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Fluidigm Corp. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Fluidigm Corp. Here are 5 ETFs with the largest exposure to FLDM-US. Comparing the performance and risk of Fluidigm Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of FLDM earnings conference call or presentation 4-May-17 9:00pm GMT

    Q1 2017 Fluidigm Corp Earnings Call

  • Capital Cube5 months ago

    ETFs with exposure to Fluidigm Corp. : May 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Fluidigm Corp. Here are 5 ETFs with the largest exposure to FLDM-US. Comparing the performance and risk of Fluidigm Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Fluidigm Corp. :FLDM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
    Capital Cube5 months ago

    Fluidigm Corp. :FLDM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017

    Categories: Yahoo FinanceGet free summary analysis Fluidigm Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Fluidigm Corp. – Illumina, Inc., NanoString Technologies, Inc., Thermo Fisher Scientific Inc., Luminex Corp, PerkinElmer, Inc., Pacific Biosciences of California, Inc. and Bio-Rad Laboratories, Inc. Class A (ILMN-US, NSTG-US, ... Read more (Read more...)

  • Associated Press5 months ago

    Fluidigm reports 1Q loss

    The South San Francisco, California-based company said it had a loss of 59 cents per share. Losses, adjusted for one-time gains and costs, came to 33 cents per share. The company that makes equipment to ...

  • Cerner (CERN) Earnings and Revenues Beat Estimates in Q1
    Zacks6 months ago

    Cerner (CERN) Earnings and Revenues Beat Estimates in Q1

    Cerner Corp (CERN) reported adjusted first-quarter 2017 earnings of 56 cents per share, beating the Zacks Consensus Estimate of 53 cents.

  • CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y
    Zacks6 months ago

    CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y

    CONMED Corporation (CNMD) reported first-quarter 2017 adjusted earnings of 38 cents per share, beating the Zacks Consensus Estimate by 4 cents.

  • Becton (BDX) Gets FDA 510(k) for New Flow Cytometer System
    Zacks6 months ago

    Becton (BDX) Gets FDA 510(k) for New Flow Cytometer System

    Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

  • Fresenius (FMS) Acquires 70% Stake in Kunming Wuhua Hospital
    Zacks6 months ago

    Fresenius (FMS) Acquires 70% Stake in Kunming Wuhua Hospital

    Fresenius Medical Care AG & Co. KGAA announced the acquisition of 70% equity interest in Kunming Wuhua Health Hospital in China.

  • Mazor Expects Higher Q1 Revenue, Receives Mazor X Orders
    Zacks6 months ago

    Mazor Expects Higher Q1 Revenue, Receives Mazor X Orders

    Mazor Robotics Ltd. (MZOR), recently announced that it expects to report record first-quarter 2017 revenue of approximately $11.5 million compared with only $6.4 million in the year-ago quarter.

  • Teleflex (TFX) Acquires Medical Device Provider Pyng Medical
    Zacks6 months ago

    Teleflex (TFX) Acquires Medical Device Provider Pyng Medical

    Teleflex Inc. (TFX), a global provider of medical technologies, announced that it has acquired Pyng Medical Corporation.

  • Becton, Dickinson Takes Over Caesarea Medical Electronics
    Zacks6 months ago

    Becton, Dickinson Takes Over Caesarea Medical Electronics

    Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has acquired Caesarea Medical Electronics.

  • Varian (VAR) Eclipse Software Tops in International Studies
    Zacks7 months ago

    Varian (VAR) Eclipse Software Tops in International Studies

    Varian Medical Systems, Inc. (VAR) recently announced that its Eclipse treatment planning software has topped in two competitive international plan studies.

  • PAREXEL (PRXL) Launches Sensor for Clinical Trial Market
    Zacks7 months ago

    PAREXEL (PRXL) Launches Sensor for Clinical Trial Market

    PAREXEL International Corporation (PRXL), a global biopharmaceutical services company and provider of clinical research and logistics, recently announced the launch of its patient sensor solution.

  • AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View
    Zacks7 months ago

    AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View

    AngioDynamics Inc. (ANGO), a leading provider of minimally invasive medical devices, reported adjusted earnings of 19 cents per share in the third quarter of fiscal 2017.

  • Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering
    Zacks7 months ago

    Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering

    Merit Medical Systems, Inc. (MMSI) announced that it has closed its follow-on public offering of 5.2 million shares of common stock at $28.25 per share.

  • Investopedia7 months ago

    Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering

    Leading manufacturer and marketer of proprietary disposable devices, Merit Medical Systems, Inc. MMSI announced that it has closed its follow-on public offering of 5.2 million shares of common stock at ...